Bacterial Biofilms Provide Clues into Colorectal Cancer Risk

A new study suggests that dense bacterial communities called biofilms may promote the development of some colorectal cancers. Source link

A Good Year: FDA Approved Nine New Cancer Drugs in 2014

In 2014, the Food and Drug Administration (FDA) approved 41 drugs that had not been approved previously for any indication,...

Precision Medicine Initiative® and Cancer Research

Under the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments...

Genome Study Yields Clues to Head and Neck Cancers

Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may...

Medicare to Cover Annual Lung Cancer Screening for Some Beneficiaries

For the first time, Medicare will cover the costs of lung cancer screening for some beneficiaries, the Centers for Medicare...

FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer

Palbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer....

Exposure to Secondhand Smoke Plummets, but Disparities Persist

Second-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed...

"Flipping the Switch": An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology Branch

NCI’s Dr. Mark Gilbert discusses new developments in neuro-oncology and the priorities of the Neuro-Oncology Branch. Source link

New from NCI: Resources, Tools, and News

NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to...